MET and mesothelioma: Biochemical analyses showed that 3 major signaling pathways were activated in mesothelioma, EGF and EGFR, VEGF and the receptors VEGFR1 and VEGFR2, and hepatocyte growth factor (HGF) and the receptor c-Met.